首页> 外文期刊>Biochemistry >Activated protein C-protein C inhibitor complex formation: characterization of a neoepitope provides evidence for extensive insertion of the reactive center loop.
【24h】

Activated protein C-protein C inhibitor complex formation: characterization of a neoepitope provides evidence for extensive insertion of the reactive center loop.

机译:活化蛋白C蛋白C抑制剂复合物复合物:新腔体的表征提供了对反应中心环的广泛插入的证据。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Protein C inhibitor, a serine proteinase inhibitor (serpin), is the physiologically most important inhibitor of activated protein C. We have made a monoclonal antibody (M36) that binds with equally high affinity to an epitope present in activated protein C-protein C inhibitor complexes and cleaved loop-inserted protein C inhibitor. Insertion of a synthetic N-acetylated tetradecapeptide (corresponding to residues P1-P14 of the reactive center loop) into beta-sheet A of the uncleaved inhibitor also exposed the epitope. The antibody had no apparent affinity for native uncleaved inhibitor or for the free peptide. Synthetic P1-P14 analogues, with Arg P13 or Ala P9 substituted to the residues found in mouse protein C inhibitor (Thr and Ile, respectively), were also inserted in beta-sheet A. The Arg P13/Thr substitution led to a greatly impaired reactivity with the antibody, whereas the Ala P9/Ile mutation resulted in a modest loss of reactivity with the antibody. These results indicate that complex formation leads to insertion of the reactive center loop in beta-sheet A from Arg P14 and presumably beyond Ala P9. Moreover, to the best of our knowledge, this is the first instance where the neoepitope of a complexation-specific monoclonal antibody has been localized to the loop-inserted part of beta-sheet A, the part of the serpin where the complexation-induced conformational change is most conspicuous.
机译:蛋白C抑制剂是丝氨酸蛋白酶抑制剂(Serpin),是生理上最重要的活化蛋白C的抑制剂。我们已经使单克隆抗体(M36)与活化的蛋白C-蛋白C抑制剂中存在的表位同等为高亲和力结合复合物和切割环状蛋白C抑制剂。将合成的N-乙酰化四肽(对应于反应中心环的残基P1-P14)进入未切割的抑制剂的β-片A,还暴露出表位。抗体对天然未切割的抑制剂或游离肽没有明显的亲和力。合成P1-P14类似物,用Arg P13或Ala P9取代于在小鼠蛋白C抑制剂(Thr和Ile)中的残基中,也插入β-纸A中。Arg P13 / Thr替换导致了大量损害与抗体的反应性,而ALA P9 / ILE突变导致与抗体的反应性损失。这些结果表明复杂的形成导致从β-片A中插入β-纸张A中的反应性中心环,并且可能超过ALA P9之外。此外,据我们所知,这是络合特异性单克隆抗体的新素已经定位在β-薄片A的环形部分,其中硅蛋白的一部分的第一实例,其中络合诱导的构象改变是最显眼的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号